Jennifer Bzowy
Women's Health · Roseburg, ORNPI 1356447924
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $551 of the $840 with a category attached, or 65.6%. 10 manufacturers reported payments, led by Astellas Pharma US Inc at 50.0% of the total. Reporting peaked in 2023 at $385 and has fallen 55.3% since, to $172 in 2024. Among women's health clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $27.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$420
- AbbVie$129
- Coopersurgical, Inc.$74
- Gen-probe Sales & Service, Inc.$74
- Hologic Sales And Service, LLC$39
- Novo Nordisk$32
- plus $71 from 4 others
What the payments were for
- Food & beverage$55166%
- Education$28934%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $420 |
| AbbVie | 7 | $129 |
| Coopersurgical, Inc. | 4 | $74 |
| Gen-probe Sales & Service, Inc. | 1 | $74 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Novo Nordisk | 2 | $32 |
| Ascend Therapeutics US, LLC | 2 | $24 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Dysis Medical, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $13 |
How this compares
$840 in reported general payments places this provider in the 90th percentile of 57 women's health providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 173 | $10,206 |
| Estradiol (Twice Weekly)Estradiol | 29 | $2,296 |
| Estradiol (Once Weekly)Estradiol | 29 | $1,751 |
| DottiEstradiol | 18 | $1,509 |
| ProgesteroneProgesterone, Micronized | 58 | $1,508 |
| Norethindrone Acetate | 12 | $951 |
| Medroxyprogesterone Acetate | 51 | $564 |
| ValacyclovirValacyclovir Hcl | 12 | $496 |
| Acyclovir | 14 | $332 |
| Clotrimazole | 16 | $279 |
| Risedronate Sodium | 11 | $142 |
| Fluconazole | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other women's health in Roseburg
- Mitzi ThompsonRoseburg$533
- Jennifer Hanlon-WildeThe Dalles$3K
- Sheryl HorwitzPortland$1K
- Michaela FrenchSpringfield$916
- Jessica BenedictHillsboro$879
- Kimberly LarsonMedford$845
- Crystal LindahlGrants Pass$830
- Nancy MacyTualatin$803
- Jade CarboyBend$705
- Shoshana FarberDallas$691
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.